Appeal No. 1998-1719 Application No. 08/442,603 doubt that the invention is patentable, resort to speculation, unfounded assumptions or hindsight reconstruction to supply deficiencies in its factual basis.” In addition, where we need specificity in the examiner’s analysis, to lead us to the modifications made in pGB20, we are only met with vagueness and generalities. We find no appreciation in the examiner’s statement that Martin could or should be modified in the manner suggested in the concurring opinion. It does not appear to us that the examiner fully appreciated the degree of specificity required to get from the gene taught by Martin, to the claimed pGB20 construct claimed. Furthermore, to the extent that the concurrence relies on Nomiya, we note that figures 1 and 2 at issue in Nomiya were labeled “prior art”. In Nomiya, the examiner’s first rejection of the appealed claims identified and specifically recognized that figures 1 and 2 illustrated the prior art. Nomiya 509 F.2d at 570, 184 USPQ at 611. Thus, from the very first rejection, Nomiya had notice of the “prior art” relied upon and an opportunity to address this “prior art.” That is not the case here. The Nomiya court also recognized, in reversing the examiner’s rejection under 35 U.S.C. § 103, that “[t]he court must be ever alert not to read obviousness into an invention on the basis of the applicant’s own statements; that is, we must view the prior art without reading into that art appellant’s teachings.” Nomiya 509 F.2d at 571, 184 USPQ at 612. 7Page: Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 NextLast modified: November 3, 2007